Answers are grounded in this paper and cite their sources.
This research demonstrates the development of hybrid compounds that target SRPK1, suggesting potential advancements in cancer therapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Leonidis et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: